BIO-key International, Inc.
BKYI
$0.715
-$0.0003-0.04%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -16.85% | -16.29% | -5.65% | -2.35% | 24.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -16.85% | -16.29% | -5.65% | -2.35% | 24.07% |
| Cost of Revenue | 1.12% | 50.05% | 127.99% | 261.68% | 194.83% |
| Gross Profit | -58.94% | -113.41% | -124.75% | -142.98% | -47.35% |
| SG&A Expenses | -12.67% | -17.58% | -14.27% | -11.46% | 10.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.34% | -0.80% | 13.52% | 29.39% | 28.77% |
| Operating Income | -0.60% | -10.89% | -29.35% | -57.11% | -32.99% |
| Income Before Tax | 26.92% | 21.79% | 10.63% | -4.40% | -79.24% |
| Income Tax Expenses | -326.14% | -325.94% | -556.86% | -556.86% | -- |
| Earnings from Continuing Operations | 29.75% | 24.55% | 11.55% | -3.46% | -80.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.75% | 24.55% | 11.55% | -3.46% | -80.95% |
| EBIT | -0.60% | -10.89% | -29.35% | -57.11% | -32.99% |
| EBITDA | 0.82% | -10.93% | -29.86% | -58.51% | -33.98% |
| EPS Basic | 61.51% | 54.38% | 39.41% | 24.40% | -63.37% |
| Normalized Basic EPS | 49.08% | 39.16% | 21.25% | -1.84% | -35.32% |
| EPS Diluted | 61.51% | 54.38% | 39.41% | 24.40% | -63.37% |
| Normalized Diluted EPS | 49.08% | 39.16% | 21.25% | -1.84% | -35.32% |
| Average Basic Shares Outstanding | 185.73% | 135.34% | 88.91% | 30.29% | 16.44% |
| Average Diluted Shares Outstanding | 185.73% | 135.34% | 88.91% | 30.29% | 16.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |